1. Academic Validation
  2. Exploiting the Cullin E3 Ligase Adaptor Protein SKP1 for Targeted Protein Degradation

Exploiting the Cullin E3 Ligase Adaptor Protein SKP1 for Targeted Protein Degradation

  • ACS Chem Biol. 2024 Feb 16;19(2):442-450. doi: 10.1021/acschembio.3c00642.
Seong Ho Hong 1 2 Anand Divakaran 1 2 Akane Osa 1 2 Oscar W Huang 3 Ingrid E Wertz 3 Daniel K Nomura 1 2 4
Affiliations

Affiliations

  • 1 Department of Chemistry, University of California, Berkeley, 2151 Berkeley Way, Room 312G, Berkeley, California 94720, United States.
  • 2 Innovative Genomics Institute, 2151 Berkeley Way, Berkeley, California 94720, United States.
  • 3 Bristol Myers Squibb, 700 Bay Road, Redwood City, California 94063, United States.
  • 4 Department of Molecular and Cell Biology, University of California, Berkeley, 2151 Berkeley Way, Room 312G, Berkeley, California 94720, United States.
Abstract

Targeted protein degradation with proteolysis targeting chimeras (PROTACs) is a powerful therapeutic modality for eliminating disease-causing proteins through targeted ubiquitination and proteasome-mediated degradation. Most PROTACs have exploited substrate receptors of Cullin-RING E3 ubiquitin ligases such as Cereblon and VHL. Whether core, shared, and essential components of the Cullin-RING E3 ubiquitin ligase complex can be used for PROTAC applications remains less explored. Here, we discovered a cysteine-reactive covalent recruiter EN884 against the SKP1 adapter protein of the SKP1-CUL1-F-box containing the SCF complex. We further showed that this recruiter can be used in PROTAC applications to degrade neo-substrate proteins such as BRD4 and the Androgen Receptor in a SKP1- and proteasome-dependent manner. Our studies demonstrate that core and essential adapter proteins within the Cullin-RING E3 ubiquitin ligase complex can be exploited for targeted protein degradation applications and that covalent chemoproteomic strategies can enable recruiter discovery against these targets.

Figures
Products